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ABSTRACT 
The changes occurring in hepatocytes of F-344 male rats during a 3-wk treatment 
with  a  hypolipidemic  agent,  1-methyl-4-piperidyl-b/s[p-chlorophenoxy]acetate 
(Sail 42-348), have been evaluated by morphometric and biochemical methods. 
The  twofold  increase  in  liver  weight  resulted  from  a  significant  increase  in 
hepatocyte cytoplasm as well as a moderate increase in the number of liver cells. 
The peroxisome population and SER played an overwhelming part in the hyper- 
trophy of hepatocytic cytoplasm. The relative volume and the surface density of 
peroxisomes increased ninefold and sevenfold, respectively. The increase in the 
collective peroxisome volume resulted from an increase in both the number and 
the  average volume of peroxisomes. The SER also  demonstrated  a  substantial 
increase in these values. The relative volume and surface density of mitochondria 
were not significantly altered in comparison to controls, while these values for 
RER decreased onefold. Studies on the lobular distribution of cytoplasmic organ- 
eUes before and during treatment revealed that the relative volume and surface 
density of peroxisomes and SER increased from periportal to centrilobular cells of 
the  hepatic  lobule, whereas mitochondrial values decreased from periportal to 
centrilobular cells. The RER values were fairly constant in different parts of the 
hepatic lobule. The increase in peroxisome and SER volume and surface area was 
first evident within  the  first  3  days of Sail  42-348  treatment  and these values 
continued to increase, reaching a  steady state within 2  wk. The time course of 
increase in catalase and carnitine acetyltransferase activities correlated with the 
morphometric data on the peroxisomes. After cessation of Sail 42-348 treatment, 
the  peroxisome  values  decreased  rapidly  within  the  first  3  days  and  reached 
control  levels within  1  wk.  Moderate  reduction  in  SER values occurred after 
withdrawal of the drug, but these values remained higher than controls even after 
2  wk,  suggesting  that  the  reduction  in  the  amount  of circulating  peroxisome 
proteins may result in empty SER channels. On the 4th day of drug withdrawal a 
significant increase in the relative volume and surface density of lysosomes was 
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cellular membranes. However, the rapid reduction in peroxisome values after Sail 
42-348 withdrawal appears to be due to cessation of enhanced peroxisome protein 
synthesis. 
The function of mammalian peroxisomes (micro- 
bodies,  microperoxisomes) has  yet  to  be  eluci- 
dated. Rhodin first described these organelles in 
the renal proximal tubule as a  single-membrane- 
limited cytoplasmic constituent with a fine granu- 
lar matrix (39). Further studies have since demon- 
strated peroxisomes in several animal tissues, pro- 
tozoans,  and plants. The  content of mammalian 
peroxisomes was shown by de Duve and co-work- 
ers to include catalase and several oxidative en- 
zymes such  as urate  oxidase, D-amino acid oxi- 
dase,  L-a-hydroxy  acid  oxidase,  and  isocitrate 
dehydrogenase (21). More recently, the activities 
of  carnitine  acetyltransferase,  NAD+:a-glycerol 
phosphate  dehydrogenase,  and  NADH-cyto- 
chrome  c  reductase  have  also  been  reported  in 
peroxisome fractions  (10,  15,  26).  One  area of 
study which may help to elucidate the function of 
peroxisomes and their contents is the use of cer- 
tain hypolipidemic drugs which have been shown 
to induce proliferation of hepatic peroxisomes. 
In 1964, Duncan and co-workers reported that 
the  hypolipidemic  drug,  clofibrate,  caused  a 
marked hepatomegaly in rats (11). The following 
year, Hess and co-workers found that the hepato- 
megaly arose from a striking proliferation of per- 
oxisomes in the liver cells (17). A  proliferation of 
the  smooth  endoplasmic  reticulum  (SER)  also 
contributed to the hepatomegaly, but to a  lesser 
extent.  Methyl clofenapate, nafenopin, and  Sail 
42-348  (1-methyl-4-piperidyl  b/s[p-chlorophen- 
oxy]acetate), which are hypolipidemic analogues 
of clofibrate, have also been found to induce hep- 
atomegaly  with  a  proliferation  of  peroxisomes 
(34, 35, 37). In addition, a few other compounds 
which are structurally unrelated to clofibrate have 
been  shown  to  induce  both  hypolipidemia and 
peroxisome  proliferation  (18,  20,  36).  On  the 
basis of this  relationship, it  has been  suggested 
that peroxisomes may be related to lipid metabo- 
lism (36). 
The  increase in peroxisome proliferation after 
treatment with these  drugs was shown  to be  ac- 
companied by an increase in catalase activity (27, 
37), the marker enzyme for peroxisomes (21). An 
increase in the  activities of camitine acetyltrans- 
ferase  (CAT)  and  NAD+:ct-glycerol phosphate 
dehydrogenase  also occurs  upon  treatment  with 
these compounds (19, 27, 37). 
The purpose of this study is to describe quanti- 
tatively the structural events which lead to hepato- 
megaly, on the basis of a  morphometric analysis 
(47, 48) of hepatocytes in rats treated with Sail 
42-348.  These structural alterations in liver cells 
are correlated with the changes in hepatic catalase 
and carnitine acetyltransferase activities. Also in- 
cluded in this report are studies on the  effect of 
withdrawal of Sail 42-348 on the reversal of per- 
oxisome proliferation, in order to assess the role 
of the lysosomal system in the removal of peroxi- 
somes. Preliminary results of this study have been 
presented elsewhere (28). 
MATERIALS  AND  METHODS 
Animals 
The animals used in these  studies were  male F-344 
rats (Simonson Laboratories Inc., Gilroy, Calif.) weigh- 
ing  130-160  g, which were  housed  in individual  steel 
cages. Sail 42-348  (Sandoz Pharmaceuticals,  Hanover, 
N.  J.)  was  mixed  with  ground  Purina  rat  chow  at  a 
concentration  of 0.10% (wt/wt). Animals received food 
and water ad libitum; control animals received a similar 
diet without the drug. 
Animals were  fasted for  12  h  and sacrificed under 
light  ether anesthesia  between  10:30  and  11:30  a.m. 
Treated animals (three per each interval) were sacrificed 
on days  1,  3,  6,  10,  14,  and  21.  After 21  days, the 
remaining animals were returned to the control diet and 
sacrificed  on  2,  4,  8,  and  14  days  after withdrawal. 
Control animals were sacrificed on days 8, 17, and 31 of 
the experiment. 
Biochemistry 
LIVER CATALASE:  Livers were perfused with iso- 
tonic saline solution via the portal vein, removed, and 
weighed. A 5% homogenate  in distilled water was pre- 
pared according to the method described previously (34) 
and the catalase activity determined spectrophotometric- 
ally at 25~  as described by LOck (25). 
LIVER  CARNITINE  ACETYLTRANSFERASE:  200~ 
homogenates  of  liver  were  prepared  in  a  buffer 
containing  116  mM  Tris-HCl,  2.5  mM  EDTA,  and 
0.25  M  sucrose  (pH  8.0).  Supernates  were  prepared 
as described previously (27) and assayed spectrophoto- 
metrically for CAT with the thioacceptor DTNB  [5,5'- 
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et al.  (26). 
LIVER  SUCCINATE  DEHYDROGENASE"  Succinate 
dehydrogenase  activity  was  measured  by  the  spec- 
trophotometric method  of Bachmann  and  co-workers 
(1) on liver homogenates in 0.25 M sucrose. 
CELL  FRACTIONATION"  Liver  homogenates  in 
0.25 M sucrose were fractionated by differential centrif- 
ugation (19). Proteins were measured by the method of 
Lowry et al. (24). 
Morphology 
Samples of liver were fixed  for  1  h  at  4~  in  2% 
osmium tetroxide buffered with s-collidine  to pH  7.4, 
and  processed as described previously  (44).  For  light 
microscopy, 1-ttm sections were stained with  toluidine 
blue and viewed in a Zeiss Ultraphot II microscope. Thin 
sections were stained with lead hydroxide and examined 
with a Hitachi Hu  11-C electron microscope at 50  kV. 
The magnification  was calibrated regularly  with a repli- 
cate diffraction grating (30  x  10  ~ lines/in). 
Morphometric Analysis 
Morphometric analysis  was performed essentially  as 
described by Weibel et al. (47). At all stages of investiga- 
tion, three blocks of tissue were randomly selected from 
each animal. Sections from these blocks were then exam- 
ined at three stages of magnification. 
s  T A G E  I:  1-tim sections stained with toluidine blue 
were examined with a Zeiss Ultraphot II microscope at a 
magnification of 1,130.  A grid (10 cm x  8 cm) contain- 
ing  cross-hatchings spaced  1  cm  apart  (63  points  of 
intersection) was drawn on a glass plate and inserted in 
place of the normal viewing  plate. 20  fields each were 
examined from groups sacrificed  on  21  days of treat- 
ment,  14  days  after withdrawal from  treatment,  and 
from control animals (blocks  from one animal were se- 
lected from each of the three control groups). 
STAG E  I I ;  Thin sections were examined under the 
electron  microscope  at  a  magnification  ranging  from 
4,030  to  4,140.  Fields of hepatocyte cytoplasm were 
selected in the random manner suggested by Weibel et 
al.  (47)  and those free of artifacts were photographed. 
Five photographs were taken per animal and 10 in x  8 in 
prints were produced from the negatives. The magnifica- 
tion of prints (-3) was determined from each negative in 
order to correct for shrinkage and other alterations from 
the photographic processing. The final magnification  at 
this stage was approximately 12,000.  Prints were ana- 
lyzed by the multipurpose test system of Weibel et al. 
(47) in which 84 lines (Z =  1.5 cm) were used, giving 
168 counting points per field. Point counting was used to 
estimate the relative volume of cytoplasmic  organelles 
and  intersections of  test  lines  with  membranes were 
counted to estimate the surface density of the respective 
limiting membranes. All organelles were analyzed at this 
lower magnification in order to minimize variation due to 
possible nonrandom distribution of certain organelles in 
hepatocytes. 
STARE  III:  Additional fields  were  analyzed  at  a 
higher magnification  (final  magnification  -23,000)  to 
increase the accuracy  of counts on membranes of low 
resolution (i.e. SER, RER, and Golgi apparatus). The 
procedure was otherwise identical  to  that of stage II, 
with five prints per animal being analyzed. No significant 
difference was found in the values determined at these 
two stages, and values were pooled for the final results. 
Therefore, a total of 30  prints per interval  for treated 
and  withdrawn animals and  20  prints per interval  for 
control animals  were evaluated. 
Analysis of Lobular Distribution 
The lobular architecture of the tissue was determined 
on toluidine blue-stained 1-/~m sections. Those demon- 
strating clearly definable centrilobular or periportal ves- 
sels were sectioned and stained with lead for examination 
under the  electron microscope. The  centrilobular and 
periportal fields were selected from three rows of hepa- 
tocytes adjacent to the respective vessels. This was based 
on  Loud's  observation  (23)  that  the  most significant 
heterogeneity of liver cells  was found  in  these  areas. 
Midzonal fields  were selected from cells at least seven 
rows away  from either group of vessels.  Photographs 
were taken of cell cytoplasm and analyzed at the magnifi- 
cation of stage III. In all,  15  prints for each area were 
analyzed on control and 21  day-treated animals. 
Calculations  and Statistics 
All the calculations  of morphometric analysis were as 
described by Weibel et al. (47). To determine the abso- 
lute values of volume (cm~/fiver) and surface  area (mZ/ 
liver) the density of liver was assumed to be 1.05 g/cm  3 
as  reported  by  Weibel  et  al.  (48).  Values calculated 
during the treatment and withdrawal  period were com- 
pared to the pooled values of the three control groups. 
Levels of significance  were  determined by  using  Stu- 
dent's two tail t-test. To compare the centrilobular, mid- 
zonal,  and  periportal  values,  the  three  groups  were 
tested for nonequality by the ANOVA one-way analysis 
as described by Dixon and Massey (9). When nonequal- 
ity was found (P <  0.05), the values that were not equal 
were determined by Duncan's multiple range test (12). 
RESULTS 
Effect on Liver Size 
On  gross  examination  of  rats  treated  with 
0.10%  Sail  42-348,  the  most noticeable altera- 
tion was the enlargement of the liver. The relative 
liver weight (RLW) of treated rats showed a rapid 
increase during the 1st wk of treatment (Fig. 1). A 
slight reduction in this trend occurred on day  10 
and  was  followed  by  a  further  increase  which 
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control  level.  Upon  withdrawal  of Sail 42-348 
from the diet, the RLW returned to control levels 
within 14 days. 
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FIGURE 1  Total liver value for the surface area of hep- 
atocyte organelles in F-344 rats receiving 0.10%  Sail 
42-348  expressed  as ratio to control values  and com- 
pared  to  the  ratio of relative  liver weight  in  treated 
animals  to  control animals.  PER,  peroxisomes;  SER, 
smooth endoplasmic  reticulum;  RER,  rough  endoplas- 
mic  reticulum;  O  M1TO, outer mitochondrial  mem- 
brane; RLW, relative liver weight. 
The  changes  in  hepatocyte  size  and  number 
were evaluated by morphometric analysis of semi- 
thin sections. It was found that the number of total 
liver nuclei increased 1.4 times over control values 
(Table I). The average hepatocyte volume, assum- 
ing one nucleus per cell, and the average nuclear 
volume (Table I) were both increased similarly, to 
1.4 times the control. This accounts for the obser- 
vation that the relative volume of hepatocyte cyto- 
plasm and  nuclei were  unchanged  from controls 
(Table  I).  The  increase  in  liver size, therefore, 
appeared to result from both hyperplasia and cel- 
lular hypertrophy. 
After discontinuation of Sail 42-348 treatment, 
the number of total liver nuclei returned to control 
levels (Table I), as did the liver size. The reversal 
of hepat0cyte size and number, however, was not 
accompanied by a reduction in the average nuclear 
volume  (Table  I).  This  was  reflected in  the  in- 
crease in the  relative nuclear volume  after with- 
drawal of the drug (Table I). 
Analysis of Ultrastructural Changes 
The  changes  in  hepatocyte  organeUes  after 
treatment with and withdrawal from 0.10%  Sail 
42-348  have  been  summarized  schematically in 
Figs. 1 and 2.  As the liver size was in a dynamic 
state during the course of the experiment (Fig. 1), 
attention has been drawn to both the total liver 
and  concentration  values,  the  latter  being  ex- 
pressed  as  the  morphometric  dimensions  origi- 
nally calculated for relative volume (cma/cm  3 hep- 
atocyte  cytoplasm) and  surface  density (m2/cm  3 
hepatocyte cytoplasm). 
As  is  evident  from  Figs.  1  and  2,  the  most 
marked change in the relative content of hepato- 
TABLE  I 
Effect of O.lO% Sail 42-348 in the Diet on the Relative Liver Weight, and the Relative Volume of Hepatocyte 
Cytoplasm and Hepatocyte Nuclei in Male Rats 
Hepatocyte  cyto-  Hepatocyte  nuclei 
plasm 
Treatment  Relative liver wt  Vv  Vv  Total liver  Nuclear volume 
g/lO0 g  rat  cm3/cm  a liver 
Control diet  2.92  -+ 0.15"  0.748  .+ 0.011 
0.10%  Sail  42-348  6.04  -+ 0.16:~  0.770  .+  0.013 
21 days 
0.10%  Sail  42-348  2.96  -+ 0.03  0.717  -+ 0.010 
21 days, with- 
drawn  14 days 
(no./cm  3  liver) 
cm3/cma liver  x  10  ~  (no./lOO g  rat)  x  tO  e  cm ~  x  10  -l~ 
0.092  +  0.004  70.28  -+ 3.79  212.1  -"  12.6  13.60 -  0.82 
0.090 -+ 0.007  49.86  -  2.35:~  301.2  •  14.6~  18.55  ---  1.55w 
0.117  •  0.006w  64.18  -+ 4.36  191.2  .+  12.4  19.45  -'-  1.32~ 
* Values expressed as mean  _+ SE. 
Significantly different from control, P  <  0.001. 
w Significantly different from control, P  <  0.01. 
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FIGURE 2  Schematic representation of volume changes in F-344 rat liver after treatment with and with- 
drawal fl'om 0.10% SaI-I 42-348 in the diet. Expressed as (a) total liver values and (b) percent of liver. 
cytes was a dramatic increase in surface area and 
volume of peroxisomes. During the 3-wk period of 
treatment, the relative volume of peroxisomes in- 
creased  from  the  control  value  of  0.0146  to 
0.1227  (cm3/cm  z hepatocyte cytoplasm). The in- 
creases in both relative volume and surface density 
were first observed on the 3rd day of treatment. 
These values increased steadily thereafter (Fig. 3). 
Upon  withdrawal  of the  drug,  the  peroxisomal 
values decreased rapidly, returning to control lev- 
els within 8 days. 
The increase in the collective peroxisomal vol- 
ume was accompanied by an increase in the num- 
ber of peroxisomes (Fig. 4a). However, while the 
relative  volume  of peroxisomes  as  a  whole  in- 
creased 8.4-fold, only a 3.1-fold increase occurred 
in the number of peroxisomes. A 2.5-fold increase 
in the average peroxisomal volume (Fig. 4b) ac- 
counted for the remaining change in the collective 
volume.  The  alteration  in  peroxisome  size  was 
further analyzed by direct measurement of peroxi- 
some radii from the electron micrographs. Mito- 
chondrial radii were also measured for compara- 
tive purposes. By use of this technique, the control 
radii of peroxisomes and mitochondria were found 
to be 0.299  -+ 0.005  tzm and 0.536 +_ 0.010/xm, 
respectively (Fig. 5). The radii of these organelles 
in animals treated with 0.10% Sail 42-348 for 21 
days were 0.362 -+ 0.008 txm for peroxisomes and 
0.534 +- 0.009 p~m for mitochondria. The increase 
in the average peroxisome radius was statistically 
significant (P <  0.001). 
The  average  radius  of  peroxisomes  was  also 
calculated from  morphometric data by using the 
relationship between the relative volume and sur- 
face density, or by using the  calculated average 
volume of peroxisome. Radii of 0.389 and 0.461 
/zm were obtained for control and treated animals, 
respectively,  from  the  surface  area-to-volume 
ratios, while radii of 0.332 and 0.451/zm for con- 
trol  and  treated  animals were  derived from  the 
average peroxisome volumes. Although the rela- 
tive  increase  in  size  was  similar  for  all  three 
methods, higher values were obtained by using the 
latter  two  indirect  methods.  The  experimental 
error  between  the  surface  area to  volume  ratio 
method  and the direct measurement was  13.1% 
for  control  and  12.2%  for  treated  groups.  The 
errors between the  average volume method and 
direct  measurement  were  5.2%  and  11.1%, 
respectively.  The  average  mitochondrial  radii 
calculated from the volume to surface area rela- 
tionship were also higher than the measured radii 
of  0.621  /zm  for  control  and  0.592  #m  for 
treated animals, with experimental error of 7.4% 
and 5.2%, respectively. 
On analysis of the lobular distribution of peroxi- 
somes, the increases in peroxisomal relative vol- 
ume  and in surface area were found to be more 
marked  in  the  centrilobular region  (Fig.  6).  A 
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FIGURE 3  Morphometric  values of hepatocyte  peroxisomes  in male  F-344 rats receiving 0.10%  Sail 
42-348 in the diet (O  O) and control animals (&--&). (a) relative volume and (b) surface density of 
limiting membrane. Significant difference from pooled control values (** P  <  0.001). 
similar, but not as significant distribution was also 
observed in control animals. 
Along with the  peroxisomes, the  volume  and 
surface area of the smooth endoplasmic reticulum 
(SER) were increased to a greater extent than the 
change in liver size (Fig. 1). The relative volume 
and surface density were increased 0.5- and  1.0- 
fold,  respectively, after 3  wk of treatment.  The 
increase in SER values was observed on the  1st 
day  of treatment  and  preceded  the  increase  in 
peroxisomes. This was associated with a decrease 
in the total and relative values of rough endoplas- 
mic reticulum (RER) on day 1 (Fig. 1). Thereaf- 
ter, the total RER values remained above control 
values, but not to the extent of change in liver size, 
so  that  a  significant decrease  was  found  in  the 
relative volume and surface density during treat- 
ment.  During  withdrawal,  the  SER  values  re- 
turned at first towards the control level, but after 4 
days only a slight decrease occurred. The relative 
volume and surface density remained significantly 
above the  control values after  14  days of with- 
drawal. As with peroxisomes, the values of SER 
volume and surface area for treated and control 
animals were highest in the centrilobular and low- 
est in the periportal regions (Fig. 6). No significant 
difference was noted in the iobular distribution of 
the RER. 
The changes in mitochondrial volume and sur- 
face area paralleled the change in liver size (Fig. 
1). The mitochondrial relative volume (Fig. 2) and 
surface densities of the outer mitochondrial mem- 
brane and inner membrane and cristae remained 
essentially unchanged during treatment and with- 
drawal  periods.  All  three  mitochondrial  values 
were higher in periportal and lower in centrilobu- 
lar regions, in contrast to peroxisomes and SER. 
The  values for  Golgi complexes  and  lysosomes 
were  not  altered  significantly during  treatment 
with 0.10%  Sail 42-348.  However, a  significant 
increase in the reJative volume and surface density 
of the  lysosomes was  noted  on  the  4th  day  of 
withdrawal  (Fig.  7).  No  significant  differences 
were  encountered  in  the  lobular distribution of 
these two organelles in either treated or control 
animals. 
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FIGURE 4  Morphometric  values of hepatocyte  peroxi- 
somes in male F-344 rats receiving 0.10% Sail 42-348 in 
the  diet  (￿9  and  control  animals  (A--A), (a) 
number of peroxisomes and (b) average volume of per- 
oxisomes (** P  <  0.001, * P <  0.01). 
lase  activity in  supernate  increased to  a  greater 
extent  when  compared  to  the  mitochondrial  + 
peroxisome fraction. 
In control animals, the distribution of CAT ac- 
tivity appeared to be intermediate between those 
of catalase  and  succinate  dehydrogenase  except 
for a  significant amount in the  microsomal frac- 
tion.  In contrast, the  distribution of CAT in  21 
day-treated animals was almost identical to that of 
catalase, suggesting that a large proportion of the 
increase in CAT activity occurred  in the  peroxi- 
somes. 
DISCUSSION 
Liver Growth and Organelle  Induction 
It has been  shown  that  the  hepatomegaly in- 
duced in rats by treatment with Sail 42-348 arose 
from a combination of hypertrophy and hyperpla- 
sia of hepatocytes. The increase in hepatocyte size 
was associated with an elevated volume of peroxi- 
somes and SER. The increase in peroxisome vol- 
ume itself was due to an increase in both the size 
and the number of these organelles. 
Peroxisome-Associated Enzymes  ,., 
The  activities of two  enzymes associated with  _~ 
peroxisomes, catalase and carnitine acetyltransfer- 
ase (CAT), and one mitochondrial enzyme, succi-  a_w 
nate  dehydrogenase,  were  measured  during  the  >- 
time course of the experiment. The total activities 
of catalase and CAT were found to increase rap-  o  la.l 
idly during treatment, reaching maximum values  ,, 
by 10 days (Fig. 8). After withdrawal of the drug, 
the activities of these two enzymes decreased rap- 
idly and reached control levels within 8 days. As  caz 
illustrated in  Fig.  8,  the  proportion  of catalase  o 
activity in the supernatant fraction, as opposed to 
the  particulate  fraction,  increased  progressively  "~  ).. 
from approximately one-half of the total in control 
LO 
animals to two-thirds in treated. After cessation of 
drug treatment, the proportion of supernatant ac- 
tivity returned to control levels. The supernatant 
activity of CAT was only one-fourth of the total 
activity in treated animals. The  activity of succi- 
nate  dehydrogenase,  however,  remained  essen- 
tially unchanged  during  the  entire  time  course. 
The subcellular distribution of the enzymes in con- 
trol  and  21  day-treated animals  is presented  in 
Fig.  9.  Control  catalase  activity was  found  pre- 
dominantly in the supematant and mitochondrial 
peroxisome fractions. In treated animals, the cata- 
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The  increase  in peroxisome  size  was  demon- 
strated by direct measurements  of profile radii and 
indirectly from morphometric data. The absolute 
values derived from these methods, however, did 
not agree for both peroxisomes and mitochondria. 
Similar discrepancies for mitochondrial measure- 
ments were noted in the results of other workers. 
Baudhuin and  Berthet  (2)  measured  mitochon- 
drial radii directly from electron micrographs of 
subcellular  fractions  and  obtained  an  average 
value of  0.382  ~m,  whereas  calculation of  the 
average radius, from the surface area to volume 
ratio reported, yielded a value of 0.437/zm. The 
experimental error between these two sets of val- 
ues was  5.9%,  as  compared  to  7.4  and  5.2%, 
respectively, in our measurements on mitochon- 
dria of control and treated animals. Calculation of 
the average mitochondrial radius from the data of 
Weibel and co-workers (48)  on relative volume 
and surface area, and average mitochondrial vol- 
ume, gave  values of 0.372  /xm  and 0.552  /zm, 
respectively. Accordingly, the indirect methods of 
measuring organelle radii  do  not  appear  to  be 
representative. However,  these  methods  appear 
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the nuclear, mitochondrial-peroxisomal, and microsomal 
fractions. 
adequate for comparison between two experimen- 
tal groups, since relative changes did correspond 
with the direct measurements. 
The proliferation of peroxisomes in these stud- 
ies was accompanied by a  proliferation of SER. 
An  increase  in  hepatocyte  SER  has  also  been 
noted in animals treated with all other compounds 
capable of inducing peroxisome proliferation (17, 
18, 20, 34-36). The proliferation of SER by these 
drugs may have been independent of the peroxi- 
some proliferation and related to the induction of 
drug-metabolizing enzymes,  as proposed for the 
compounds (such as phenobarbital [6]) which in- 
duce  solely  the  SER.  Slight  increases  in  cyto- 
chrome  P-450,  metabolism of testosterone,  and 
N-demethylase activity have been reported in rats 
treated with Sail 42-348  and clofibrate, suggest- 
ing  induction  of microsomal  enzymes  (40,  45). 
However,  the  increases were  not  as  marked  as 
those seen in animals treated with phenobarbital. 
It is also possible that the increase in SER may 
have arisen in relation to the peroxisome prolifer- 
ation. The composition of SER and peroxisome- 
limiting membranes has been shown to be similar 
(10).  On  ultrastructural observation, continuities 
have been noted frequently between peroxisomes 
and  the  SER  (29).  Therefore,  it  has been  pro- 
posed  that  peroxisomes arise  from  the  ER  and 
may  exist as a  common  pool in  continuity with 
parts of the ER (30, 33). As the proliferation of 
SER preceded the increase in peroxisomes, SER 
proliferation in this instance may have occurred, in 
part, as a  precursor to peroxisome proliferation. 
The  finding  of  an  initial decrease  in  the  total 
amount of RER coincided with the initial increase 
in SER. It has been shown recently that the ratio 
of free  to  bound  ribonucleoprotein increases in 
rats treated with clofibrate (31),  an  analogue of 
Sail 42-348,  and may represent fall-off of poly- 
somes from the RER, thus accounting in part for 
the initial changes in SER and RER values. 
The possible relationship between the SER and 
peroxisomes was also exemplified by the similarity 
of  their  lobular  distributions.  The  finding  of  a 
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FIGURE 9  Subcellular  distribution  of (a)  catalase,  (b) 
carnitine  acetyltransferase,  and  (c)  succinate  dehydro- 
genase.  Ordinate  expressed  as cumulative  percent of 
protein, abscissa as the relative specific enzyme activity 
(percent  of total enzyme  activity/fraction,  divided by 
percent of total protein (fraction). 
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centrilobular region is in agreement with Loud's 
morphometric studies (23)  and with the findings 
of Wanson and co-workers that centrilobular hep- 
atocytes separated  on  a  Ficoll gradient  contain 
more SER than the other cells (46). 
Distribution patterns for the  peroxisomes and 
SER  were  amplified,  but  remained  unchanged 
after treatment with 0.10% of Sail 42-348. While 
this  finding  was  not  adequate  to  determine 
whether or not the  proliferation of these  organ- 
elles was initiated in a particular region, studies on 
clofibrate and nafenopin have shown (3) that cel- 
lular  hypertrophy  and,  one  may  therefore,  as- 
sume, the organelle proliferation were first noted 
in  the  centrilobular region.  It therefore  appears 
that, as with agents such as phenobarbital (41) and 
CC14 (32) which affect the SER, the initial effect 
of peroxisome  proliferator drugs  occurs  in  that 
region where these organelles predominate. 
The relative volume and surface density of mito- 
chondria were not affected by the administration 
of Sail 42-348. The total liver values of mitochon- 
dria  increased in  parallel with  liver size,  as  re- 
ported previously for clofibrate and methyl clofen- 
apate (28). Gear reported similar findings in rats 
treated with clofibrate using a particle counter on 
isolated liver mitochondria (14). Others, however, 
have  noted  an  increase  in  the  concentration  of 
mitochondrial protein after treatment with clofi- 
brate or methyl clofenapate (19). An increase in 
the protein content of an organelle may not neces- 
sarily contradict the lack of increase in the volume 
or surface area of that organelle. The increase in 
mitochondrial protein content may be due  to an 
increase in the protein density within the matrix or 
membrane. However, in the case of drugs which 
induce proliferation of peroxisomes that sediment 
close to mitochondria, contamination of the mito- 
chondrial fraction with peroxisomes may account 
for some of the changes observed in that fraction. 
The increase in total liver mitochondrial values in 
animals treated with this peroxisome proliferator 
is in contrast to the finding, that SER proliferation 
predominates  and  the  total  liver  mitochondrial 
volume  remains  unchanged  in  animals  treated 
with  phenobarbital  (43).  Therefore,  it  appears 
that the increase in mitochondrial values is not a 
general phenomenon  related to the liver growth. 
Withdrawal 
The liver size of treated rats reverted to control 
levels within 2 wk after the withdrawal of Sail 42- 
348  from  the  diet.  This was  accompanied by  a 
similar reversal in all the organelles analyzed, ex- 
cept for the SER. In this and the previous study, 
which  utilized clofibrate and  methyl clofenapate 
(28), the values for the SER decreased, but only 
partially, so that they were still significantly ele- 
vated at 2 wk after withdrawal. 
Bolender and Weibel have shown in their mor- 
phometric study that the SER induced by pheno- 
barbital reverted to control levels within  5  days 
after withdrawal of treatment (4). It is conceivable 
that  the  prolonged  period of regression for  the 
SER in the  present study may have  arisen from 
the  longer period  of treatment,  21  days as  op- 
posed to 5 days in Bolender and Weibel's study. 
However,  the  increase in  SER  was of a  similar 
magnitude at the end point of both experiments. 
Although the half-life of Sail 42-348 has not been 
reported, the  rapid reversal in  other parameters 
measured suggests that it is not too prolonged and 
may  be  comparable  to  that  of  phenobarbital. 
Therefore, if the mechanism of reversion in both 
cases was the  same,  one would expect to find a 
similar time period for the removal of these mem- 
branes. 
Bolender and Weibel found that the removal of 
SER  was  associated with  a  marked  increase  in 
autophagic  vacuoles  (4).  Therefore,  the  mem- 
brane  removal was attributed to intracellular se- 
questration,  followed  either  by  secretion  or  by 
digestion through the lysosomes (7). In this study, 
when  lysosomes were  loosely defined to  include 
autophagic vacuoles and dense bodies, a  marked 
increase in the  lysosome relative volume  and  in 
the surface density were seen on the 4th day after 
withdrawal of Sail 42-348 from the diet. A  major 
decrease in the peroxisomes and SER did occur at 
the  same  time.  Therefore,  the  lysosome system 
may have played an important role in the removal 
of these  organelles, although  direct evidence  of 
increased  numbers  of  autophagic  vacuoles  con- 
taining SER or peroxisomes was not encountered. 
If autophagy indeed played a role in the disposal 
of peroxisomes, the absence of autophagic vacu- 
oles containing peroxisomes during reversal may 
be due  either to  rapid dissolution of the  peroxi- 
somal matrix upon ingestion or to incorporation of 
peroxisomes into the autophagic vacuole by fusion 
(8). 
The turnover of peroxisomes in the natural state 
is not  fully understood  as yet,  but  a  half-life of 
1.5-3 days has been reported. The rate of regres- 
sion in peroxisomes after the withdrawal of Sail 
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fore,  the  removal of peroxisomes may have  re- 
sulted  from  cessation  of  induced synthesis and 
return to a normal steady state. When one consid- 
ers  the  prolonged increase of part  of the  SER, 
peroxisomes may be  removed by  absorption of 
their contents within the SER (34) while, concur- 
rently, portions of the SER are being sequestered. 
This would be compatible with the idea suggested 
earlier that peroxisomes may exist as a continuity 
with  the  SER  (34).  The  persistent elevation of 
SER during reversal as shown by these morpho- 
metric studies is a  strong indication that  peroxi- 
somal matrix proteins are removed by absorption 
and the empty limiting membranes contribute to 
increases in SER values. 
Peroxisome-Associated  Enzymes 
The induction of peroxisomes was accompanied 
by an increase in the activity of two enzymes which 
are associated with peroxisomes. In all of the cases 
where these enzymes were studied, the activities 
of catalase and CAT have been found to increase 
after administration of drugs which induce peroxi- 
some proliferation (27, 36,  37). The function of 
these enzymes in the induced peroxisomes has not 
yet been determined. 
The distribution pattern of CAT in treated ani- 
mals was almost identical to that of catalase when 
compared, after differential centrifugation, to the 
distribution of mitochondrial enzyme dehydrogen- 
ase  and  the  peroxisomal  enzyme  catalase.  The 
increased catalase and CAT activities in the super- 
natant fraction in treated animals appear to be due 
to  release  of  these  enzymes from  peroxisomes 
during homogenization, since morphological evi- 
dence indicates that peroxisomal proteins accumu- 
late in dilated SER channels and that these organ- 
elles are  continuous with one  another (22,  33). 
The  distribution of hepatic CAT activity in rats 
treated  with  clofibrate  was  studied  recently by 
Goldenberg et al. (16). They found approximately 
equal increases in the  mitochondrial and peroxi- 
somal fractions isolated by isopycnic gradient cen- 
trifugation. Our results appear to indicate a similar 
response in rats treated with Sail 42-348, an ana- 
logue of clofibrate, and the enzyme activity cor- 
relates well with the  morphometric data  on  the 
increase in peroxisomes. 
The function of CAT in peroxisomes, as well as 
in other organelles, has not been fully elucidated. 
The enzyme does appear to function in the trans- 
fer  across  the  membranes  of  short-chain  acyl 
groups and may play a role in biological acetyla- 
tion and fatty acid synthesis (5, 13, 42). It there- 
fore  appears  significant that  such  a  marked  in- 
crease in CAT activity occurs in association with 
peroxisome proliferation, since all compounds ca- 
pable  of inducing peroxisome  proliferation also 
possess hypolipidemic activity (36). The associa- 
tion between CAT increase and peroxisome pro- 
liferation may in part help to clarify the relation- 
ship between peroxisomes and lipid metabolism. 
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